These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18672781)

  • 1. [Clinical application of Tripterygium wilfordi for treatment of gynecologic diseases].
    Luo LP; Tan BZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 May; 28(5):473-5. PubMed ID: 18672781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gn-RH analogs in the treatment of benign gynecologic diseases: current trends].
    Framarino dei Malatesta ML; Veneziano M; Scarazzo T; Paolucci A; Bandiera AF; Fiorelli C; Mileto F; D'Anna A
    Minerva Ginecol; 1995 Sep; 47(9):349-53. PubMed ID: 8545034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tripterygium wilfordii Hook F. versus Sulfasalazine in the treatment of rheumatoid arthritis: a well-designed clinical trial of a botanical demonstrating effectiveness.
    Marks WH
    Fitoterapia; 2011 Jan; 82(1):85-7. PubMed ID: 21126560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gynecological indications of a new progestational agent with prolonged action].
    Goisis M; Candotti G
    Minerva Ginecol; 1970 Mar; 22(6):339-67. PubMed ID: 5515153
    [No Abstract]   [Full Text] [Related]  

  • 5. Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents.
    Wong KF; Yuan Y; Luk JM
    Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):311-20. PubMed ID: 21834865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mifepristone. Auxiliary therapeutic use in cancer and related disorders.
    Koide SS
    J Reprod Med; 1998 Jul; 43(7):551-60. PubMed ID: 9693404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extract of Tripterygium wilfordii Hook F protect dopaminergic neurons against lipopolysaccharide-induced inflammatory damage.
    Liu Y; Chen HL; Yang G
    Am J Chin Med; 2010; 38(4):801-14. PubMed ID: 20626064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory effects of leaf and twig of Tripterygium wilfordii on paw edema in mice.
    Yu L; Ao M; Wan J; Zhang Y
    Fitoterapia; 2008 Dec; 79(7-8):529-32. PubMed ID: 18672035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and experimental study on sustained release tablet of Tripterygium wilfordii in treating rheumatoid arthritis].
    Li RL; Liu PL; Wu XC
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Jan; 16(1):10-3. PubMed ID: 8732122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of a gonadotropin-releasing hormone agonist for treating gynecological diseases].
    Merser LJ; Jilbert HM; Chen P
    Akush Ginekol (Mosk); 1991 Feb; (2):16-20. PubMed ID: 1862845
    [No Abstract]   [Full Text] [Related]  

  • 11. [Active ingredients, pharmacological action and clinical application of Tripterygium wilfordii].
    Wang CD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Aug; 13(8):507-9. PubMed ID: 8111203
    [No Abstract]   [Full Text] [Related]  

  • 12. Levonorgestrel-releasing intrauterine system: uses and controversies.
    Bahamondes L; Bahamondes MV; Monteiro I
    Expert Rev Med Devices; 2008 Jul; 5(4):437-45. PubMed ID: 18573044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of total alkaloids of Tripterygium wilfordii Hook f. on collagen-induced arthritis in rats.
    Zhang Y; Xu W; Li H; Zhang X; Xia Y; Chu K; Chen L
    J Ethnopharmacol; 2013 Feb; 145(3):699-705. PubMed ID: 23183089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiangiogenic agents in natural products for the treatment of gynecologic disorders.
    Aghamohammadi A; Hosseinimehr SJ
    Nutr Cancer; 2014; 66(2):206-13. PubMed ID: 24410431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of bone loss in patient treated with Gn-Rh analogs].
    Cassese E; Piscitelli V; Farzati A; Balbi GC; Balbi C
    Minerva Ginecol; 1997 Jun; 49(6):255-9. PubMed ID: 9289664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Nanomedicine in Benign Gynecologic Disorders.
    Lulseged BA; Ramaiyer MS; Michel R; Saad EE; Ozpolat B; Borahay MA
    Molecules; 2024 May; 29(9):. PubMed ID: 38731586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The anti-inflammatory effect of niflumic acid in gynaecological diseases].
    Legros R; Coiffard P
    Rev Fr Gynecol Obstet; 1973 Jun; 68(6):467-9. PubMed ID: 17474656
    [No Abstract]   [Full Text] [Related]  

  • 18. Introduction of LHRH-antagonists into the treatment of gynaecological disorders.
    Reissmann T; Diedrich K; Comaru-Schally AM; Schally AV
    Hum Reprod; 1994 May; 9(5):769. PubMed ID: 7929720
    [No Abstract]   [Full Text] [Related]  

  • 19. Duphaston depot, a new long-acting progestogen.
    Schellen AM
    Bull Soc R Belge Gynecol Obstet; 1969; 39(4):327-31. PubMed ID: 5408050
    [No Abstract]   [Full Text] [Related]  

  • 20. [Advance in the anti-tumor mechanism of triptolide].
    Luo Y; Shi C; Liao M
    Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(16):2024-6. PubMed ID: 19938536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.